Our results suggest that Aβ42, t-tau, p-T181-tau, and p-S396-tau in BDE may be effective biomarkers, as detection strategies based on novel biomarkers, like Aβ and tau proteins could represent a promising solution for the early diagnosis of AD [8]. This evidence concerns the gene MAPT and Alzheimer disease.